Tailored Oils via Recombinant Enzyme Segmentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing oils with specific fatty acid profiles and regiospecific distributions in microorganisms are limited in their ability to achieve stable and efficient production of triglycerides with desired fatty acid compositions, particularly in terms of high oleic or mid-chain fatty acids, and stability.

Innovation Solution

Cultivating recombinant oleaginous cells that express specific genes such as KASI, KASII, LPAAT, SAD, FAD2, and FATB genes under nitrogen-sensitive promoters, and using knockout or knockdown strategies to control fatty acid biosynthesis pathways, resulting in oils with tailored fatty acid profiles and regiospecific distributions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional methods are used to produce oils in microorganisms, then general oil production is achieved, but the ability to achieve stable and efficient production of triglycerides with desired fatty acid compositions is limited

Engineering Contradiction:
Improvefatty acid composition controlVSAvoidproduction stability
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The patent segments the fatty acid biosynthesis pathway into multiple controllable steps by introducing specific enzymes (KASI, KASII, LPAAT, SAD, FAD2, FATB) that catalyze individual reactions. Each enzyme can be independently regulated to control the final fatty acid composition, allowing precise manufacturing of triglycerides with desired profiles while maintaining production stability through systematic control of each pathway segment.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs nitrogen-sensitive promoters to dynamically control gene expression levels of fatty acid biosynthesis enzymes based on nitrogen availability. This parameter change approach allows the system to switch between growth mode (nitrogen replete) and storage mode (nitrogen limited), thereby stabilizing production while achieving desired fatty acid compositions through regulated enzyme activity.

Inventive Principle:
Principle #35Parameter changes

2Stability of the object's composition

If generic oil production methods are used, then oil is produced, but oils with high oleic or mid-chain fatty acids and enhanced stability cannot be achieved

Engineering Contradiction:
Improveoxidative stabilityVSAvoidoil production efficiency
Core Design Contradiction:
Stability of the object's compositionVSProductivity

Solution Approach 1:

The patent introduces specific enzymes with localized functions in the fatty acid biosynthesis pathway: KASI and KASII for chain elongation, LPAAT for lysophosphatidic acid acyltransferase activity, SAD for stearoyl-ACP desaturase function, FAD2 for fatty acid desaturase activity, and FATB for fatty acid thioesterase activity. Each enzyme imparts specific local quality control over fatty acid chain length, saturation level, and regiospecific distribution, achieving high oxidative stability without sacrificing overall production efficiency.

Inventive Principle:
Principle #3Local quality

3Manufacturing precision

If traditional fatty acid biosynthesis pathways are used, then basic oil production occurs, but regiosspecific distributions of fatty acids in triglycerides cannot be achieved

Engineering Contradiction:
Improveregiosspecific distribution controlVSAvoidgenetic engineering complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent uses acyl-ACP (acyl carrier protein) as an intermediary molecule that shuttles fatty acid chains between enzymes in the biosynthesis pathway. This intermediary mechanism allows precise control over which fatty acids are incorporated into triglycerides at specific positions (regiospecificity), as the acyl-ACP intermediates can be selectively processed by different enzymes (KASI, KASII, LPAAT, FATB) to achieve desired distribution patterns despite the complexity of the genetic engineering required.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS10053715B2Tailored oils
Publication Date: 2018.08.21 CORBION BIOTECH INC
  • US10053715B2 patent drawing
  • US10053715B2 patent drawing
  • US10053715B2 patent drawing

AI summary

Recombinant DNA techniques are used to produce oleaginous recombinant cells that produce triglyceride oils having desired fatty acid profiles and regiospecific or stereospecific profiles. Genes manipulated include those encoding stearoyl-ACP desaturase, delta 12 fatty acid desaturase, acyl-ACP thioesterase, ketoacyl-ACP synthase, and lysophosphatidic acid acyltransferase. The oil produced can have enhanced oxidative or thermal stability, or can be useful as a frying oil, shortening, roll-in shortening, tempering fat, cocoa butter replacement, as a lubricant, or as a feedstock for various chemical processes. The fatty acid profile can be enriched in midchain profiles or the oil can be enriched in triglycerides of the saturated-unsaturated-saturated type.